Reversible neurologische Komplikationen bei der Schaum-Sklerotherapie

• Literatur

• 1 Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005; 31: 123-8.
• 2 Breu FX, Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy, April, 4–6, 2003, Tegernsee, Germany. Dermatol Surg 2004; 30: 709-17.
• 3 Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28: 11-5.
• 4 Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004; 30: 1386-90.
• 5 Yamaki T, Nozaki M, Iwasaka S. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 2004; 30: 718-22.
• 6 Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 2004; 30: 6-12.
• 7 Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003; 29: 1170-5.
• 8 Künzlberger B, Pieck C, Altmeyer P, Stücker M. Migraine ophthalmique mit reversiblen Skotomen nach Sklerosierungstherapie mit Polidocanol. 46. Jahrestagung der Deutschen Gesellschaft für Phlebologie. Recklinghausen. 22.-25.09.2004.
• 9 Horton SC, Bunch TJ. Patent foramen ovale and stroke. Mayo Clin Proc 2004; 79: 79-88.
• 10 Morrison N. Simultaneous echocardiography and transcranial Doppler with ultrasound foam guided sclerotherapy. 18th Annual Meeting of the American Venous Forum. Miami: Feb.22–26 2006
• 11 Breu FX, Marshall M, Guggenbichler S. Prospektive Studie über die Schaum-Sklerotherapie: die ersten drei Jahre. 46. Jahrestagung der Deutschen Gesellschaft für Phlebologie. Recklinghausen: 22.-25.09 2004